The U.S. government sided with mammography yesterday in the ongoing battle over breast screening. A government task force updated its recommendation by calling for screening mammography every one to two years for women ages 40 and over.
The U.S. Preventive Services Task Force had previously recommended that routine screening begin at age 50. In updating its advisory, the USPSTF cited the results of eight randomized clinical trials published since it last updated its recommendation in 1996.
"Mammography is an important tool for detecting breast cancer," said Janet Allan, RN, PhD, vice chair of the USPSTF. "Clinicians and women should discuss individual risk factors to determine when to have a first mammogram and how often to have them after that."
At the same time, the National Cancer Institute reaffirmed its support of mammography. The USPSTF’s guidelines now match those of the NCI, which recommends screening for women in their 40s and older. The USPSTF is sponsored by the Agency for Healthcare Research and Quality, at the Department of Health and Human Services.
The debate over mammography screening intensified in January when a Physician Data Query (PDQ) panel claimed that there was no evidence to demonstrate that mammography lowers breast cancer mortality. The panel is sponsored by the NCI, but serves in an advisory role and does not set NCI guidelines.
By AuntMinnie.com staff writersFebruary 22, 2002
Related Reading
Mammography screening effective when data are analyzed correctly, February 1, 2002
ACR blasts PDQ decision, January 28, 2002
Panel casts more doubt on mammography's value, January 24, 2002
Danish mammographers exclude dissenting opinion, October 23, 2001
Copyright © 2002 AuntMinnie.com











![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






